These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11516566)

  • 1. Bradykinin antagonist decreases early disruption of the blood-spinal cord barrier after spinal cord injury in mice.
    Pan W; Kastin AJ; Gera L; Stewart JM
    Neurosci Lett; 2001 Jul; 307(1):25-8. PubMed ID: 11516566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.
    Pan W; Csernus B; Kastin AJ
    J Mol Neurosci; 2003; 21(2):173-84. PubMed ID: 14593216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI.
    Pan W; Zhang L; Liao J; Csernus B; Kastin AJ
    J Neuroimmunol; 2003 Jan; 134(1-2):111-7. PubMed ID: 12507778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion.
    Pan W; Kastin AJ
    Exp Neurol; 2001 Aug; 170(2):357-63. PubMed ID: 11476601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of a potent bradykinin B2 receptor antagonist HOE-140 on microvascular permeability, blood flow disturbances, edema formation, cell injury and nitric oxide synthase upregulation following trauma to the spinal cord.
    Sharma HS; Feng L; Muresanu DF; Castellani RJ; Sharma A
    Int Rev Neurobiol; 2019; 146():103-152. PubMed ID: 31349925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the transport system for TNFalpha at the blood-brain barrier.
    Pan W; Kastin AJ
    Arch Physiol Biochem; 2001 Oct; 109(4):350-3. PubMed ID: 11935370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury.
    Pan W; Kastin AJ; Bell RL; Olson RD
    J Neurosci; 1999 May; 19(9):3649-55. PubMed ID: 10212323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine and vitamin C synergistically inhibits blood-spinal cord barrier disruption and improves functional recovery after spinal cord injury.
    Lee JY; Choi HY; Yune TY
    Neuropharmacology; 2016 Oct; 109():78-87. PubMed ID: 27256500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated transport of LIF across blood-spinal cord barrier is upregulated after spinal cord injury.
    Pan W; Cain C; Yu Y; Kastin AJ
    J Neuroimmunol; 2006 May; 174(1-2):119-25. PubMed ID: 16563523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury.
    Lee JY; Choi HY; Ahn HJ; Ju BG; Yune TY
    Am J Pathol; 2014 Nov; 184(11):2985-3000. PubMed ID: 25325922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury.
    Pan W; Banks WA; Kastin AJ
    Exp Neurol; 1997 Aug; 146(2):367-73. PubMed ID: 9270046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dl-3-n-butylphthalide prevents the disruption of blood-spinal cord barrier via inhibiting endoplasmic reticulum stress following spinal cord injury.
    Zheng B; Zhou Y; Zhang H; Yang G; Hong Z; Han D; Wang Q; He Z; Liu Y; Wu F; Zhang X; Tong S; Xu H; Xiao J
    Int J Biol Sci; 2017; 13(12):1520-1531. PubMed ID: 29230100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.
    Kumar H; Ropper AE; Lee SH; Han I
    Mol Neurobiol; 2017 Jul; 54(5):3578-3590. PubMed ID: 27194298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an NK1 receptor antagonist on blood spinal cord barrier permeability following balloon compression-induced spinal cord injury.
    Leonard AV; Vink R
    Acta Neurochir Suppl; 2013; 118():303-6. PubMed ID: 23564154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury.
    Pannu R; Christie DK; Barbosa E; Singh I; Singh AK
    J Neurochem; 2007 Apr; 101(1):182-200. PubMed ID: 17217414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury.
    Lee JY; Kim HS; Choi HY; Oh TH; Yune TY
    Brain; 2012 Aug; 135(Pt 8):2375-89. PubMed ID: 22798270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CORM-2-Solid Lipid Nanoparticles Maintain Integrity of Blood-Spinal Cord Barrier After Spinal Cord Injury in Rats.
    Joshi HP; Kumar H; Choi UY; Lim YC; Choi H; Kim J; Kyung JW; Sohn S; Kim KT; Kim JK; Han IB
    Mol Neurobiol; 2020 Jun; 57(6):2671-2689. PubMed ID: 32300934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemin induces heme oxygenase-1 in spinal cord vasculature and attenuates barrier disruption and neutrophil infiltration in the injured murine spinal cord.
    Yamauchi T; Lin Y; Sharp FR; Noble-Haeusslein LJ
    J Neurotrauma; 2004 Aug; 21(8):1017-30. PubMed ID: 15319001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of nuclear factor erythroid 2-related factor 2 genotype on tumor necrosis factor-α and metalloproteinase-9 expression in spinal cord after spinal cord injury in mice].
    Mao L; Wang HD; Wang XL; Qiao L; Yin HX
    Zhonghua Wai Ke Za Zhi; 2010 Oct; 48(20):1569-72. PubMed ID: 21176673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury.
    Lee JY; Choi HY; Na WH; Ju BG; Yune TY
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2403-12. PubMed ID: 25261791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.